Mendelspod Podcast

20:07

The Studies Are In—Optical Mapping Can Replace...

Mendelspod Podcast ·

2021/07/12

We’re all aware of the way that next gen sequencing has changed many tests in the clinical laboratory. But some testing has held stubbornly resistant to change. This has been the case in cytogenetics, or the analysis of chromosomes. That is now changing thanks to a technology that is making inroads where next gen sequencing could not. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

32:20

Amy Sturm of Geisinger on FH Testing and New...

Mendelspod Podcast ·

2021/07/07

"We have all of these evidence based tools and evidence based methods, but the problem is it can take upwards of 20 plus years to be truly implemented into care where healthcare providers are using them and patients are receiving them. And this includes medications and diagnostic tools and other types of treatment or screening.” This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

27:46

Out of the Reductionist Trap: Brad Gray of NanoString...

Mendelspod Podcast ·

2021/05/19

One of the hottest new trends in biomedical research today is what is known as spatial biology--the ability to capture tissues in a 3D context. It was named Method of the Year by Nature Magazine in 2020.And one of the first automated instruments launched in this market was the GeoMx Digital Spatial Profiler by NanoString. CEO Brad Gray is here to tell us the story of the birth of the DSP and the revolution of 3D biology. What will these new tools enable for the basic and translational researcher

en

36:08

Precision Oncology at the Community Level with Lee...

Mendelspod Podcast ·

2021/05/06

When Lee Schwartzberg did his training as an oncologist some thirty years ago at Memorial Sloan Kettering in New York, he had a dream. And after training, he set off to make that dream a reality: to bring the resources, expertise, and research that one enjoys at a major research hospital cancer center to the community level. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

32:55

Daniel Kraft on the Digitome and COVID

Mendelspod Podcast ·

2021/04/19

“The new drug is the engaged individual,” says today’s guest, Daniel Kraft.Daniel is the founder of Exponential Medicine where he has championed digital health and the explosion of wearable technologies. He's also hosting the new Healthy Conversations podcast--go check it out! There you will find interviews with the innovator’s of today’s medical culture, including shows with former FDA Director, Scott Gottlieb, and genomic medicine guru, Eric Topol. This is a public episode. If you'd like to

en

37:41

Orchid Health Is 1st in the World to Offer Whole...

Mendelspod Podcast ·

2021/04/07

First comes love, then comes marriage; then comes the genomic couple's report. Isn't that how the line goes?Perhaps that's a how it will begin to go.Today's guest is the founder of Orchid Health, which as of this week is offering the world’s first risk prediction couple’s report. Based on whole genome sequencing from a saliva sample that expectant parents take from home, the report will tell them their genetic risk for the major diseases, including brain, heart, cancer, diabetes, and inflammatory

en

32:23

PacBio and Labcorp Team Up on a Global Pan-Pathogen...

Mendelspod Podcast ·

2021/04/01

Will there be a fourth surge of COVID here in the U.S.? Already that we’re asking the question and it’s not an inevitability is a good sign. It’s become a race between vaccination clinics and viral variants.The U.S. was a bit slow to this race, but we are catching up. Viral surveillance has become a key part of any nation’s pandemic strategy. This past month, PacBio and Labcorp announced a partnership that brings the tool of long read sequencing to this effort. This is a public episode. If

en

37:10

Will High Sensitivity Proteomics Enable a New...

Mendelspod Podcast ·

2021/03/23

Kevin Hrusovosky’s career has been dedicated to transforming medicine from reactive “sick care” to preventative personalized care. A serial entrepreneur, he currently serves as the CEO of Quanterix, a company which has just nabbed $700 million and is raising the bar on proteomics testing.“Genomics can tell you what your predisposition is,” he says in today’s interview, “proteomics can tell you the earliest moment you are in a disease cascade.” This is a public episode. If you'd like to discuss this

en

32:01

A Liquid Biopsy Technology that Doesn't Degrade the...

Mendelspod Podcast ·

2021/03/11

Raj Krishnan has a good story, and probably a good product. More data will tell. He's the CEO of Biological Dynamics, a new liquid biopsy company that is able to detect biomarkers in not only blood but other biological fluids. And the company's products are good for not only cancer but Alzheimer's and other disease areas as well.Raj comes to precision medicine from electrical engineering. You don't hear that very often. One day in his lab while working on his PhD he had a classic eureka

en

55:01

The Future of Big Biology: Bionano at AGBT

Mendelspod Podcast ·

2021/03/04

Mendelspod was live this week at AGBT 2021 where Theral interviewed CEO Erik Holmlin and CMO Alka Chaubey of Bionano Genomics on Tuesday. The topic was the future of big biology. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

23:48

Playing Catch Up--Viral Surveillance in the U.S. with...

Mendelspod Podcast ·

2021/02/16

How fast is the coronavirus mutating? Why is the U.K. variant, or B.1.1.7, more transmissible than original strains of the virus? Is viral surveillance the weak spot in the U.S.'s fight against the pandemic? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

38:12

The Coronavirus, A Year On with Carl Zimmer

Mendelspod Podcast ·

2021/01/28

It’s been a year since the coronavirus breached American shores. Here to look back with some perspective is New York Times science writer, Carl Zimmer. Carl has authored thirteen books on science, including Planet of Viruses which includes an essay titled, "Predicting the Next Plague." This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

37:48

Spatial Biology Enables The Cancer Immunome Project

Mendelspod Podcast ·

2021/01/21

We’ve all heard of and perhaps worked with data from The Cancer Atlas Project. Now, with the help of new spatial biology tools, researchers at the Mayo Clinic are developing what they call The Cancer Immunome Project. This is a comprehensive effort to fully characterize the immune system and how it interacts with and fights off cancer.Today we talk with J C Villasboas, a physician-scientist at Mayo who co-started the project. He’s also Director of Mayo’s Immune Monitoring Core Facility. This is

en

60:25

The CRISPR Saga with Kevin Davies

Mendelspod Podcast ·

2020/12/22

A discovery here. A paper there. An important paper gets passed over. A fortuitous encounter in a coffee shop among two ambitious scientists. A yogurt company just being a yogurt company. Science moves forward in fits and starts.By the time we read the headline in the paper, “breakthrough of the year,” it can have an inevitable quality about it. Then, in a few years, the historian comes and shows us just how random, messy, and, yes, how beautiful is the business of science. This is a public episode

en

39:35

PacBio’s Never Been Stronger: New CEO, Christian...

Mendelspod Podcast ·

2020/12/15

At the beginning of the year, we were all holding our breath for the future of PacBio. And by all, I mean all. It seems everyone has been rooting for this sequencing technology company.And why? It’s simple. Pretty much everyone is in agreement that they have the highest quality reads on the market. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

58:14

Keith Robison on the State of Sequencing: 2020 Edition

Mendelspod Podcast ·

2020/11/17

We speak directly with the Oracle today. It's Keith Robison, blogger at Omics Omics. Your All Knowingness, we ask, what has happened in the world of sequencing technology this year?“The companies may need a mulligan,” he quips and laughs. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

59:24

Halloween with Nathan and Laura: The Spooky and...

Mendelspod Podcast ·

2020/10/30

Our October Review show is a Halloween special this year. Join us around the campfire amidst the sounds of howling wolves as Nathan, Laura, and Count Theracula recall some of their creepiest and spookiest times in the world of genomics.It's Mendelspod's Haunted House of the Genome. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

37:41

When and Why Whole Genome Sequencing Should Be...

Mendelspod Podcast ·

2020/10/27

There’s an urgency about Stephen Kingsmore. Which is not to say he’s in a rush.He’s the CEO of the Rady’s Children’s Genomics Institute. He and his team have two world records to their name for the incredible speed of diagnosing a rare disease using whole genome sequencing. The latest is 19.5 hours.Dr. Kingsmore feels they can even shave time off that. They’re shooting for a new record of somewhere around 12 hours. This is a public episode. If you'd like to discuss this with other subscribers or

en

33:10

Limited Genetic Diversity Affects Us All

Mendelspod Podcast ·

2020/10/22

Diversity’s in the news these days. It's not just political correctness. Let’s look deeper into our field at how limited diversity in genetics is affecting all of us.If you are a member of a minority population and you go into a cancer clinic seeking help, some of the genetic tests on offer may not work for you because of your ethnic background. Not only is this wrong on a social justice level. It turns out it's just bad science. This is a public episode. If you'd like to discuss this with other

en

41:05

Genomics England Making Significant Strides in System...

Mendelspod Podcast ·

2020/10/08

“In an era where we look at these surveys about trust and everything’s going off the cliff, everyone still trusts the NHS. It’s so deep in the British psyche." This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

All Episodes

Similar Podcasts

Mendelspod Podcast

Theral Timpson

DMCN Journal

John Wiley & Sons Ltd

汪诘：科学有故事（主打）

科学有故事

天方烨谈

基因频道

Homesteading and Permaculture by Paul Wheaton

paul wheaton